Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1996. Start Trial.
Date Value
March 31, 2026 2.042B
December 31, 2025 2.036B
September 30, 2025 2.036B
June 30, 2025 2.035B
March 31, 2025 2.035B
December 31, 2024 2.029B
September 30, 2024 2.028B
June 30, 2024 2.027B
March 31, 2024 2.027B
December 31, 2023 2.021B
September 30, 2023 2.035B
June 30, 2023 2.089B
March 31, 2023 2.101B
December 31, 2022 2.098B
September 30, 2022 2.126B
June 30, 2022 2.135B
March 31, 2022 2.129B
December 31, 2021 2.176B
September 30, 2021 2.220B
June 30, 2021 2.222B
March 31, 2021 2.233B
December 31, 2020 2.244B
September 30, 2020 2.260B
June 30, 2020 2.254B
March 31, 2020 2.263B
Date Value
December 31, 2019 2.228B
September 30, 2019 1.629B
June 30, 2019 1.636B
March 31, 2019 1.636B
December 31, 2018 1.624B
September 30, 2018 1.632B
June 30, 2018 1.632B
March 31, 2018 1.635B
December 31, 2017 1.625B
September 30, 2017 1.637B
June 30, 2017 1.640B
March 31, 2017 1.647B
December 31, 2016 1.664B
September 30, 2016 1.671B
June 30, 2016 1.671B
March 31, 2016 1.669B
December 31, 2015 1.661B
September 30, 2015 1.668B
June 30, 2015 1.668B
March 31, 2015 1.667B
December 31, 2014 1.653B
September 30, 2014 1.659B
June 30, 2014 1.658B
March 31, 2014 1.657B
December 31, 2013 1.641B

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Johnson & Johnson 2.407B
Eli Lilly & Co. 943.50M
Merck & Co., Inc. 2.470B
Pfizer Inc. 5.699B
AstraZeneca PLC 3.102B